Literature DB >> 3510997

Cell kinetics and radiation biology.

J Denekamp.   

Abstract

The cell cycle, the growth fraction and cell loss influence the response of cells to radiation in many ways. The variation in radiosensitivity around the cell cycle, and the extent of radiation-induced delay in cell cycle progression have both been clearly demonstrated in vitro. This translates into a variable time of expression of radiation injury in different normal tissues, ranging from a few days in intestine to weeks, months or even years in slowly proliferating tissues like lung, kidney, bladder and spinal cord. The radiosensitivity of tumours, to single doses, is dominated by hypoxic cells which arise from the imbalance between tumour cell production and the proliferation and branching of the blood vessels needed to bring oxygen and other nutrients to each cell. The response to fractionated radiation schedules is also influenced by the cell kinetic parameters of the cells comprising each tissue or tumour. This is described in terms of repair, redistribution, reoxygenation and repopulation. Slowly cycling cells show much more curved underlying cell survival curves, leading to more dramatic changes with fractionation, dose rate or l.e.t. Rapidly cycling cells redistribute around the cell cycle when the cells in sensitive phases have been killed, and experience less mitotic delay than slowly proliferating cells. Reoxygenation seems more effective in tumours with rapidly cycling cells and high natural cell loss rates. Compensatory repopulation within a treatment schedule may spare skin and mucosa but does not spare slowly proliferating tissues. Furthermore, tumour cell proliferation during fractionated radiotherapy may be an important factor limiting the overall success of treatment.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3510997     DOI: 10.1080/09553008514552591

Source DB:  PubMed          Journal:  Int J Radiat Biol Relat Stud Phys Chem Med        ISSN: 0020-7616


  42 in total

Review 1.  Therapeutic inhibition of angiogenesis.

Authors:  Hua-Tang Zhang; Roy Bicknell
Journal:  Mol Biotechnol       Date:  2003-10       Impact factor: 2.695

Review 2.  Integrin signalling and the cellular response to ionizing radiation.

Authors:  Nils Cordes; Viktor Meineke
Journal:  J Mol Histol       Date:  2004-03       Impact factor: 2.611

3.  Analysis of Radiomodulatory Effect of Low-Level Laser Irradiation by Clonogenic Survival Assay.

Authors:  Gholamreza Esmaeeli Djavid; Bahram Goliaie; Alireza Nikoofar
Journal:  Photomed Laser Surg       Date:  2015-09       Impact factor: 2.796

Review 4.  Modifiers of radiosensitivity.

Authors:  A Rojas; J Denekamp
Journal:  Experientia       Date:  1989-01-15

Review 5.  Cell kinetics and radiation pathology.

Authors:  J Denekamp; A Rojas
Journal:  Experientia       Date:  1989-01-15

6.  Advances in cell kinetics.

Authors:  D A Rew; G D Wilson
Journal:  BMJ       Date:  1991-09-07

7.  Different effect of granulocyte colony-stimulating factor or bacterial infection on bone-marrow cells of cyclophosphamide-treated or irradiated mice.

Authors:  A M Buisman; T L Van Zwet; J A Langermans; M F Geertsma; P J Leenen; R van Furth
Journal:  Immunology       Date:  1999-08       Impact factor: 7.397

8.  Crypt base columnar stem cells in small intestines of mice are radioresistant.

Authors:  Guoqiang Hua; Tin Htwe Thin; Regina Feldman; Adriana Haimovitz-Friedman; Hans Clevers; Zvi Fuks; Richard Kolesnick
Journal:  Gastroenterology       Date:  2012-07-27       Impact factor: 22.682

9.  Critical parameters determining standard radiotherapy treatment outcome for glioblastoma multiforme: a computer simulation.

Authors:  D D Dionysiou; G S Stamatakos; D Gintides; N Uzunoglu; K Kyriaki
Journal:  Open Biomed Eng J       Date:  2008-09-10

10.  Applying a 4D multiscale in vivo tumor growth model to the exploration of radiotherapy scheduling: the effects of weekend treatment gaps and p53 gene status on the response of fast growing solid tumors.

Authors:  Dimitra D Dionysiou; Georgios S Stamatakos
Journal:  Cancer Inform       Date:  2007-02-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.